相似文献
1
COPD exacerbations.5: management.
Thorax. 2006 Jun;61(6):535-44. doi: 10.1136/thx.2005.041863.
2
[Treatment guidelines for chronic obstructive pulmonary disease].
Duodecim. 1999;115(22):2496-505.
3
ABC of chronic obstructive pulmonary disease. Acute exacerbations.
BMJ. 2006 Jul 8;333(7558):87-9. doi: 10.1136/bmj.333.7558.87.
4
Acute exacerbations of chronic obstructive pulmonary disease.
Emerg Med Clin North Am. 2003 May;21(2):331-52, viii. doi: 10.1016/s0733-8627(03)00014-2.
5
Impact and prevention of severe exacerbations of COPD: a review of the evidence.
Int J Chron Obstruct Pulmon Dis. 2017 Oct 5;12:2891-2908. doi: 10.2147/COPD.S139470. eCollection 2017.
6
Acute COPD exacerbations.
Clin Chest Med. 2014 Mar;35(1):157-63. doi: 10.1016/j.ccm.2013.11.001.
7
Exacerbations of chronic obstructive pulmonary disease: definition, aetiology and management.
Clin Med (Lond). 2009 Apr;9(2):170-3. doi: 10.7861/clinmedicine.9-2-170.
8
Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med. 2002 Mar 28;346(13):988-94. doi: 10.1056/NEJMcp012477.
9
Recent Advances in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Med Clin North Am. 2020 Jul;104(4):615-630. doi: 10.1016/j.mcna.2020.02.003.
10
The clinical and integrated management of COPD.
Sarcoidosis Vasc Diffuse Lung Dis. 2014 May 12;31 Suppl 1:3-21.
引用本文的文献
1
Intravenous Magnesium Sulphate as an Adjuvant Therapy for Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
Life (Basel). 2025 Jun 18;15(6):973. doi: 10.3390/life15060973.
2
Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial.
Korean J Anesthesiol. 2020 Dec;73(6):509-517. doi: 10.4097/kja.19418. Epub 2020 Feb 28.
3
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
4
Single-Center Retrospective Evaluation of Inhaled Corticosteroid Use for Chronic Obstructive Pulmonary Disease Exacerbation Patients Receiving Systemic Corticosteroids.
Hosp Pharm. 2016 Nov;51(10):841-846. doi: 10.1310/hpj5110-841.
5
The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infection.
Int J Chron Obstruct Pulmon Dis. 2016 Mar 14;11:535-42. doi: 10.2147/COPD.S96541. eCollection 2016.
6
Tiotropium Attenuates Virus-Induced Pulmonary Inflammation in Cigarette Smoke-Exposed Mice.
J Pharmacol Exp Ther. 2016 Jun;357(3):606-18. doi: 10.1124/jpet.116.232009. Epub 2016 Mar 25.
7
The effects of a physical activity counseling program after an exacerbation in patients with Chronic Obstructive Pulmonary Disease: a randomized controlled pilot study.
BMC Pulm Med. 2015 Nov 4;15:136. doi: 10.1186/s12890-015-0126-8.
8
Relationship between Dysphagia and Exacerbations in Chronic Obstructive Pulmonary Disease: A Literature Review.
Int Arch Otorhinolaryngol. 2015 Jan;19(1):74-9. doi: 10.1055/s-0034-1376430. Epub 2014 Nov 6.
9
Impact of an educational intervention on steroid prescribing and dosing effect on patient outcomes in COPD exacerbations.
Pharm Pract (Granada). 2010 Jul;8(3):162-6. doi: 10.4321/s1886-36552010000300002. Epub 2010 Mar 15.
10
The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.
PLoS One. 2014 Jun 27;9(6):e101228. doi: 10.1371/journal.pone.0101228. eCollection 2014.
本文引用的文献
1
Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2006 Apr 19(2):CD004403. doi: 10.1002/14651858.CD004403.pub2.
2
COPD exacerbations . 3: Pathophysiology.
Thorax. 2006 Apr;61(4):354-61. doi: 10.1136/thx.2005.041830.
3
Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1510-6. doi: 10.1164/rccm.200504-595OC. Epub 2005 Sep 15.
4
Physiological changes during symptom recovery from moderate exacerbations of COPD.
Eur Respir J. 2005 Sep;26(3):420-8. doi: 10.1183/09031936.05.00136304.
5
Is this the beginning of unravelling the puzzle of COPD exacerbations?
Eur Respir J. 2005 Sep;26(3):376-8. doi: 10.1183/09031936.05.00076205.
6
Factors affecting survival of hospitalised patients with COPD.
Eur Respir J. 2005 Aug;26(2):234-41. doi: 10.1183/09031936.05.00024804.
7
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
Eur Respir J. 2005 Aug;26(2):214-22. doi: 10.1183/09031936.05.00140404.
8
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Thorax. 2005 Nov;60(11):925-31. doi: 10.1136/thx.2005.040527. Epub 2005 Jul 29.
9
Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Thorax. 2005 Sep;60(9):713-7. doi: 10.1136/thx.2004.036046. Epub 2005 Jun 6.
10
COPD: current therapeutic interventions and future approaches.
Eur Respir J. 2005 Jun;25(6):1084-106. doi: 10.1183/09031936.05.00139104.
Zotero 插件